Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Greenville, NC
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Greenville, NC
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Winston-Salem, NC
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Beachwood, OH
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Beachwood, OH
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Bend, OR
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Bend, OR
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Providence, RI
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Providence, RI
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Orangeburg, SC
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Orangeburg, SC
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Dallas, TX
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Lufkin, TX
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Lufkin, TX
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Suffolk, VA
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Suffolk, VA
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Milwaukee, WI
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
mi
from
Camperdown,
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
mi
from
Camperdown,
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Saint George, UT
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Saint George, UT
Click here to add this to my saved trials
Effect of Cytokines on Growth of Children With Chronic Kidney Failure
Cytokines and Growth in Children With CRI and ESRD
Status: Enrolling
Updated:  11/17/2017
Weill Medical College of Cornell University
mi
from
New York, NY
Effect of Cytokines on Growth of Children With Chronic Kidney Failure
Cytokines and Growth in Children With CRI and ESRD
Status: Enrolling
Updated: 11/17/2017
Weill Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
Safety of Low Dose Intravenous Contrast 64 Multi-Detector Computed Tomography Scanning in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  11/26/2017
VA Greater Los Angeles Healthcare System
mi
from
Los Angeles, CA
Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
Safety of Low Dose Intravenous Contrast 64 Multi-Detector Computed Tomography Scanning in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 11/26/2017
VA Greater Los Angeles Healthcare System
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Minocycline to Prevent Acute Kidney Injury After Cardiac Surgery
Minocycline to Prevent Acute Kidney Injury After Cardiac Surgery
Status: Enrolling
Updated:  11/27/2017
Saint Louis University
mi
from
Saint Louis, MO
Minocycline to Prevent Acute Kidney Injury After Cardiac Surgery
Minocycline to Prevent Acute Kidney Injury After Cardiac Surgery
Status: Enrolling
Updated: 11/27/2017
Saint Louis University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Minocycline to Prevent Acute Kidney Injury After Cardiac Surgery
Minocycline to Prevent Acute Kidney Injury After Cardiac Surgery
Status: Enrolling
Updated:  11/27/2017
Montefiore Medical Center
mi
from
Bronx, NY
Minocycline to Prevent Acute Kidney Injury After Cardiac Surgery
Minocycline to Prevent Acute Kidney Injury After Cardiac Surgery
Status: Enrolling
Updated: 11/27/2017
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Status: Enrolling
Updated:  12/4/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Status: Enrolling
Updated: 12/4/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Status: Enrolling
Updated:  12/4/2017
University of California, San Diego
mi
from
San Diego, CA
A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Status: Enrolling
Updated: 12/4/2017
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Status: Enrolling
Updated:  12/4/2017
Stanford University
mi
from
Stanford, CA
A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Status: Enrolling
Updated: 12/4/2017
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Status: Enrolling
Updated:  12/4/2017
Eastern Idaho Medical Consultants LLC
mi
from
Idaho Falls, ID
A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Status: Enrolling
Updated: 12/4/2017
Eastern Idaho Medical Consultants LLC
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Status: Enrolling
Updated:  12/4/2017
University of Texas- Houston Medical School
mi
from
Houston, TX
A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Status: Enrolling
Updated: 12/4/2017
University of Texas- Houston Medical School
mi
from
Houston, TX
Click here to add this to my saved trials
A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Status: Enrolling
Updated:  12/4/2017
Medizinische Universität Innsbruck
mi
from
Innsbruck,
A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Status: Enrolling
Updated: 12/4/2017
Medizinische Universität Innsbruck
mi
from
Innsbruck,
Click here to add this to my saved trials
A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Status: Enrolling
Updated:  12/4/2017
UPMC
mi
from
Pittsburgh, PA
A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Status: Enrolling
Updated: 12/4/2017
UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
University of Arizona
mi
from
Tucson, AZ
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
University of California at Los Angeles
mi
from
Los Angeles, CA
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
USC/University Hospital
mi
from
Los Angeles, CA
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
USC/University Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
St. Vincent Medical Center - Los Angeles
mi
from
Los Angeles, CA
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
St. Vincent Medical Center - Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
California Institute of Renal Research
mi
from
San Diego, CA
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
California Institute of Renal Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
University of California, San Francisco Medical Center
mi
from
San Francisco, CA
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
University of California, San Francisco Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
University of Colorado, School of Medicine
mi
from
Aurora, CO
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
University of Colorado, School of Medicine
mi
from
Aurora, CO
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
Denver Nephrologists, PC
mi
from
Denver, CO
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
Denver Nephrologists, PC
mi
from
Denver, CO
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
Yale University-Yale New Haven Hospital
mi
from
New Haven, CT
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
Yale University-Yale New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
Tampa General Hospital
mi
from
Tampa, FL
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
Emory Healthcare - Emory University Hospital (EUH)
mi
from
Atlanta, GA
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
Emory Healthcare - Emory University Hospital (EUH)
mi
from
Atlanta, GA
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
Northwestern Memorial Hospital
mi
from
Chicago, IL
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
Northwestern Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
University of Illinois Mecial Center
mi
from
Chicago, IL
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
University of Illinois Mecial Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
University of Chicago Medical Center
mi
from
Chicago, IL
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
Lutheran Kidney Transplant Center
mi
from
Fort Wayne, IN
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
Lutheran Kidney Transplant Center
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
Iowa Clinic
mi
from
Des Moines, IA
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
Iowa Clinic
mi
from
Des Moines, IA
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
Maine Medical Center
mi
from
Portland, ME
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
Maine Medical Center
mi
from
Portland, ME
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
University of Maryland Medical Center
mi
from
Baltimore, MD
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
Baystate Medical Center
mi
from
Springfield, MA
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
Baystate Medical Center
mi
from
Springfield, MA
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
St. Clair Nephrology Research
mi
from
Detroit, MI
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
St. Clair Nephrology Research
mi
from
Detroit, MI
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
University of Minnesota Medical Center
mi
from
Minneapolis, MN
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
University of Minnesota Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
Columbia University Medical Center
mi
from
New York, NY
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
New York- Presbyterian/ Weill Cornell Medical Canter
mi
from
New York, NY
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
New York- Presbyterian/ Weill Cornell Medical Canter
mi
from
New York, NY
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
Carolinas Medical Center
mi
from
Charlotte, NC
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated:  12/6/2017
The Christ Hospital Cancer Research
mi
from
Cincinnati, OH
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Evaluating Nulojix Long-Term Safety in Transplant
Status: Enrolling
Updated: 12/6/2017
The Christ Hospital Cancer Research
mi
from
Cincinnati, OH
Click here to add this to my saved trials